Evidence map›Paper›PMID 28338619›Full record

ArticleInternational journal of molecular sciences2017

Role and Function of A

Annalisa Ravani, Fabrizio Vincenzi, Alessandra Bortoluzzi, Melissa Padovan, Silvia Pasquini, Stefania Gessi, Stefania Merighi, Pier Andrea Borea, Marcello Govoni, Katia Varani

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. ABMC musculoskeletal disorders · 2022
    Article
  14. Article
  15. Article
  16. ACells · 2021
    Review
  17. Adenosine and Inflammation: Here, There and Everywhere.International journal of molecular sciences · 2021
    Review
  18. Article
  19. Review
  20. Adenosine Signaling in Autoimmune Disorders.Pharmaceuticals (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Annalisa RavaniDepartment of Medical Sciences, Pharmacology Unit, University of Ferrara, 44121 Ferrara, Italy. rvnnls@unife.it.
Fabrizio VincenziDepartment of Medical Sciences, Pharmacology Unit, University of Ferrara, 44121 Ferrara, Italy. vncfrz@unife.it.
Alessandra BortoluzziDepartment of Medical Sciences, Section of Rheumatology, University of Ferrara and Azienda Ospedaliero Universitaria Sant'Anna, 44124 Cona, Ferrara, Italy. brtlsn@unife.it.
Melissa PadovanDepartment of Medical Sciences, Section of Rheumatology, University of Ferrara and Azienda Ospedaliero Universitaria Sant'Anna, 44124 Cona, Ferrara, Italy. pdvmss@unife.it.
Silvia PasquiniDepartment of Medical Sciences, Pharmacology Unit, University of Ferrara, 44121 Ferrara, Italy. psqslv@unife.it.
Stefania GessiDepartment of Medical Sciences, Pharmacology Unit, University of Ferrara, 44121 Ferrara, Italy. gss@unife.it.
Stefania MerighiDepartment of Medical Sciences, Pharmacology Unit, University of Ferrara, 44121 Ferrara, Italy. mhs@unife.it.
Pier Andrea BoreaDepartment of Medical Sciences, Pharmacology Unit, University of Ferrara, 44121 Ferrara, Italy. bpa@unife.it.
Marcello GovoniDepartment of Medical Sciences, Section of Rheumatology, University of Ferrara and Azienda Ospedaliero Universitaria Sant'Anna, 44124 Cona, Ferrara, Italy. gvl@unife.it.
Katia VaraniDepartment of Medical Sciences, Pharmacology Unit, University of Ferrara, 44121 Ferrara, Italy. vrk@unife.it.
University of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) are chronic inflammatory rheumatic diseases that affect joints, causing debilitating pain and disability. Adenosine receptors (ARs) play a key role in the mechanism of inflammation, and the activation of A

Indexed as

AdenosineAdenosine A2 Receptor AgonistsAdenosine A2 Receptor AntagonistsAdenosine A3 Receptor AgonistsAdenosine A3 Receptor AntagonistsArthritis, PsoriaticArthritis, RheumatoidCase-Control StudiesCytokinesFemaleHumansKineticsLymphocytesMaleMatrix Metalloproteinase 1Matrix Metalloproteinase 32-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosineAdenosineAdenosine A2 Receptor AgonistsAdenosine A2 Receptor AntagonistsAdenosine A3 Receptor AgonistsAdenosine A3 Receptor AntagonistsCytokinesMatrix Metalloproteinase 1Matrix Metalloproteinase 3NF-kappa BPhenethylaminesPyrazolesPyrimidinesReceptor, Adenosine A2AReceptor, Adenosine A3RNA, MessengerSCH 442416adenosine receptorsankylosing spondylitisinflammationpsoriatic arthritisrheumatoid arthritis

Identifiers

PMID28338619
PMCPMC5412283
OpenAlexW2598022013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.